PlateLens
PrivateLast Round
Series B
May 15, 2026
Est. Valuation
$400M
Total Funding Raised
$500,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
PlateLens operates in Healthcare & Life Sciences and is based in The Woodlands, Texas. Its latest recorded funding round was an Accelerator round in June 2024.
PlateLens is a health technology company that provides an AI-powered calorie and nutrition tracking application designed to analyze meals through photo recognition.
Sector
Healthcare & Life Sciences
Verticals
Sports & Fitness, Computer Vision, Subscription Commerce, Healthcare Analytics
Business Model
B2C
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PlateLens Comparables
Compare PlateLens with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nutrola | 89% | |
| Nommie | 85% | |
| Phone Eats First | 85% |
For institutional investors. Book with your work email.
PlateLens Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
PlateLens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
$50M round raised
- Jun 1, 2024
$500K round led by Y Combinator
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asOct 5, 2026
PlateLens is recognized as the best overall calorie counting app in a guide published on Oct 5th '26, citing its lowest calorie error in a six-app weighed-meal study and one-step photo and voice logging.
- launchesAug 8, 2026
In Aug '26, PlateLens ships a full web app and an MCP server, enabling users to work on a food diary from a keyboard and read it with an AI assistant.
For institutional investors. Book with your work email.
PlateLens Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PlateLens's valuation, stock price, and market status.
Is PlateLens a public or private company?
PlateLens is a private company.
What is the current stock price of PlateLens?
PlateLens is a private company, so its shares have no public market price. Caplight tracks PlateLens's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PlateLens worth (valuation)?
PlateLens's valuation is estimated at $400.0M based on funding round data.
Can I buy PlateLens stock?
PlateLens shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PlateLens's last funding round?
PlateLens's most recent funding round was Series B on May 15, 2026.
Who are the main investors in PlateLens?
Key investors in PlateLens include Y Combinator.
Will PlateLens IPO soon?
No public IPO plans have been announced for PlateLens.
How can I track PlateLens secondary market activity?
Caplight tracks bids, offers, and trades in PlateLens's shares on secondary markets.